SofSera

SofSera is a Japanese biotechnology company specializing in the development of advanced drug delivery systems using proprietary silica nanoparticle technology. The company's core platform, SofSera Silica Vehicle (SSV), utilizes porous silica particles to enhance the stability and delivery of vaccines and therapeutic agents. SofSera is actively developing a next-generation COVID-19 vaccine and exploring applications in transdermal drug delivery and oncology. Their technology aims to provide needle-free or more efficient administration routes for various biologics and small molecules. The company's inorganic approach offers potential advantages in thermal stability compared to traditional lipid nanoparticle systems.